Table 1.
Clinical stage of oral MM from dogs included in the study
Group | Stage II | Stage III |
---|---|---|
Overall population (n=33) | 10 (30.3)a | 23 (69.7)a |
Group Ib (n=14) | 5 (35.7) | 9 (64.3) |
Group IIc (n=13) | 3 (23.1) | 10 (76.9) |
Group IIId (n=6) | 2 (33.3) | 4 (66.7) |
Group II+III (n=19) | 5 (26.3) | 14 (73.7) |
% in brackets
CSPG4-positive MM; vaccinated dogs
CSPG4-positive MM; non vaccinated dogs
CSPG4-negative MM; non vaccinated dogs